Navigation Links
Radiation before surgery cuts cancer reappearance

According to a report, giving radiation to surgical treatment for rectal cancer may not make much difference in the survival of patients. But the findings suggest that the radiation treatments given before surgery may help// improve the patient's quality of life by reducing the rate of cancer recurrence at or near the original tumor site in the rectum.

In about 15% to 45% of patients who undergo conventional surgery to remove rectal tumors, they return. To prevent recurrence, surgeons have developed a technique called total mesorectal excision, in which the tissue surrounding the rectum, which may contain tumor cell, is removed along with the rectum itself.

In order to investigate researchers randomly assigned more than 1,800 patients to have either total mesorectal excision alone, or the surgery along with radiation given beforehand.

According to Dr. Ellen Kapit and colleagues from Leiden University Medical Center in New Jersy, among patients who received both radiation treatment and surgery, 2.4% saw a reappearance of their cancer. Patients in the surgery-only group had a recurrence rate of 8.2%. They concluded that radiation before surgery can improve local control of the disease.

Drs. Heidi Nelson and Daniel J. Sargent of the Mayo Clinic in Rochester, Minnesota, wrote in an accompanying editorial that the preliminary results show that radiation therapy does provide an additional benefit: radiation therapy reduced the risk of local recurrence even when administered to patients who underwent total mesorectal excision.


'"/>




Page: 1

Related medicine news :

1. Radiation before surgery cuts cancer recurrence
2. UV Radiation induces Melanoma
3. Radiation reduces cancer recurrence
4. Radiation Not Needed for Childhood Cancers
5. Does Radiation Cause Lung Cancer?
6. Radiation for Bone Pain
7. Radiation for Bone Pain
8. Radiation after Breast Reconstruction
9. Radiation Exposure Found To Affect Intellect Later In Life
10. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
11. Radiation Therapy for Prostate Cancer Tolerated Well by Elderly Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: